jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Radical neck dissection Biopsy

Biopsy
image

Report in 240Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Histopathology of dissected tissue.

₹888₹1,269

30% OFF

Radical Neck Dissection Biopsy - Comprehensive Medical Guide

  • Why is it done?
    • Test Purpose: A radical neck dissection biopsy is a surgical procedure that involves the removal and histopathological examination of lymph nodes and surrounding tissues in the neck region. It is performed to detect metastatic cancer, particularly from head and neck malignancies.
    • Primary Indications:
    • Diagnosis of metastatic cervical lymph node disease from head and neck cancers (oral cavity, pharynx, larynx)
    • Staging of known primary malignancies to determine lymph node involvement (N-staging)
    • Treatment of cervical lymph node metastases to improve local disease control and survival
    • Evaluation of lymphomas and other lymphoproliferative disorders affecting cervical nodes
    • Assessment of metastases from thyroid, melanoma, or other systemic malignancies
    • Timing: Typically performed following diagnosis of a primary head and neck malignancy or when imaging studies reveal suspicious cervical lymphadenopathy. May be performed as a therapeutic procedure to remove affected lymph nodes.
  • Normal Range
    • Reference Standard:
    • Normal Result: Negative for malignancy - No cancer cells identified in excised lymph nodes or soft tissues
    • Normal Histology: Benign reactive lymphoid hyperplasia, normal follicular architecture, absence of malignant cells
    • Node Count: Variable depending on extent of dissection; typically 10-50+ lymph nodes retrieved
    • Result Classification:
    • Negative (N0): No metastatic disease identified; lymph nodes are reactive or normal
    • Positive (N+): Metastatic carcinoma or lymphoma identified; further specified by number of involved nodes and extranodal extension
    • Borderline Findings: Atypia of uncertain significance, inconclusive features, or benign processes mimicking malignancy
    • Measurement Units: Qualitative histopathologic findings; quantitative measures include number of positive nodes, size of metastases, and presence/absence of extranodal extension
  • Interpretation
    • Negative for Malignancy (N0): Indicates absence of cancer in dissected lymph nodes; suggests early-stage disease or successful response to treatment; may affect staging and treatment planning
    • Positive for Metastatic Carcinoma: Confirms lymph node involvement; important for TNM staging and prognosis; affects treatment decisions including need for adjuvant therapy (chemotherapy or radiation)
    • Number of Positive Nodes: N1 (1-3 nodes), N2 (4+ nodes, or single node >3cm, or multiple nodes <6cm with extranodal extension), N3 (nodes >6cm in largest dimension); increases with node count and predicts worse prognosis
    • Extranodal Extension (ENE): Presence indicates spread beyond lymph node capsule into surrounding soft tissue; associated with aggressive biology and worse prognosis; influences radiation therapy planning
    • Tumor Histology and Differentiation: Well-differentiated tumors generally have better prognosis than poorly differentiated; specific histologic subtypes may have prognostic significance
    • Lymphoma Diagnosis: Identification of lymphoma type (Hodgkin vs non-Hodgkin, specific B-cell or T-cell subtype) requires immunophenotyping and molecular studies; influences treatment protocols and prognosis significantly
    • Benign Conditions: Reactive lymphoid hyperplasia from infection or inflammation; tuberculosis; fungal infections; sarcoidosis; silicosis; may require additional workup depending on clinical context
    • Factors Affecting Interpretation: Surgical technique and specimen handling, adequacy of sampling, pathologist expertise, presence of crush artifact or cautery effect, patient's immune status, prior radiation or chemotherapy
  • Associated Organs
    • Primary Organ Systems:
    • Lymphatic System: Cervical lymph nodes are the primary focus; part of regional lymphatic drainage from head and neck structures
    • Head and Neck Structures: Oral cavity, pharynx, larynx, tongue, tonsils, salivary glands, thyroid are primary cancer sources; cervical skin and ear can also be involved
    • Immunologic System: Lymph nodes are crucial immune organs; assessment reveals function and pathology of immune response
    • Respiratory Tract: Involvement may affect airway function if extensive disease present
    • Conditions Associated with Abnormal Results:
    • Squamous Cell Carcinoma: Most common malignancy; originates from oral cavity, pharynx, or larynx; represents 90% of head and neck cancers
    • Adenocarcinoma: Arises from salivary glands or other adenocarcinomas; more aggressive behavior and higher recurrence rates
    • Melanoma: Can metastasize to cervical nodes; associated with poor prognosis when present
    • Thyroid Carcinoma: Papillary or follicular types; may present with cervical node involvement at diagnosis
    • Lymphomas: Hodgkin lymphoma or non-Hodgkin lymphoma; may present primarily in cervical nodes
    • Leukemia: Can involve lymph nodes; usually systemic presentation
    • Infectious Diseases: Tuberculosis causing lymph node enlargement and caseating granulomas; fungal infections; CMV; toxoplasmosis
    • Systemic Inflammatory Conditions: Sarcoidosis, silicosis, reactive hyperplasia from chronic infection or immune stimulation
    • Complications and Risks Associated with Abnormal Results:
    • Disease Progression: Metastatic involvement in lymph nodes indicates advanced stage; higher risk of systemic dissemination and mortality
    • Treatment-Related Morbidity: Radical neck dissection may result in shoulder dysfunction, nerve injury (spinal accessory, hypoglossal), sensory changes, or cosmetic concerns
    • Recurrence Risk: Presence of metastases increases likelihood of local-regional recurrence; may require adjuvant radiation or chemotherapy
    • Wound Complications: Infection, hematoma, seroma, or fistula formation post-operatively
    • Airway Compromise: Significant lymph node disease may compress airways; post-operative edema can further compromise airway
  • Follow-up Tests
    • Recommended Follow-up Tests Based on Results:
    • Immunohistochemical (IHC) Studies: Performed on positive cases to determine tumor origin when primary is unknown or to confirm diagnosis; markers include cytokeratins, p63, p16 (HPV status), and site-specific markers
    • Flow Cytometry: For suspected lymphomas; determines B-cell or T-cell lineage and abnormal populations; essential for lymphoma classification
    • Molecular Studies: HPV testing for squamous cell carcinomas; FISH for translocations in lymphomas; gene mutation analysis for specific diagnoses
    • Imaging Studies: PET-CT to detect systemic disease; CT or MRI for treatment planning; chest X-ray to screen for pulmonary metastases
    • Tumor Markers: Serum markers (AFP, CEA, PSA) depending on suspected primary malignancy
    • Staging Studies: Bone scan, liver function tests, or targeted imaging based on tumor type and stage
    • Further Investigations if Uncertain Diagnosis:
    • Additional sections: Re-sectioning and deeper levels of specimen blocks if initial findings are equivocal
    • Electron microscopy: May be useful for specific diagnoses or ultrastructural analysis
    • Consultation with subspecialty pathologists: Head and neck pathology expert review if diagnosis remains uncertain
    • Clinical Monitoring and Surveillance:
    • Physical Examination: Every 4-12 weeks for first 2 years after surgery; then every 3-6 months for years 2-5; then annually thereafter for recurrent disease detection
    • Imaging Surveillance: Baseline post-operative imaging; follow-up imaging based on clinical suspicion or symptom development; surveillance protocols differ for different cancer types
    • Adjuvant Treatment Decisions: Positive results typically lead to consideration of radiation therapy or chemoradiation; intensity and field depend on stage and risk factors
    • Treatment Response Assessment: If patient underwent neoadjuvant therapy, repeat imaging or endoscopy may be warranted before surgical dissection
    • Complementary Diagnostic Tests:
    • Endoscopy (laryngoscopy, nasopharyngoscopy, esophagoscopy): To identify or confirm primary tumor and assess extent of disease
    • Biopsy of Primary Site: If primary tumor not yet identified or if diagnosis from node suggests need for primary tumor evaluation
    • Sentinel Node Biopsy: For select cases where staging and extent of dissection needs clarification
  • Fasting Required?
    • Fasting Requirement: YES
    • Fasting Duration: Minimum 6-8 hours before surgery is typically required; standard NPO (nothing by mouth) status must be observed prior to general anesthesia
    • Specific Pre-operative Instructions:
    • Nothing to eat or drink: After midnight before morning surgery; typically 8-12 hours before procedure depending on surgical time
    • Liquids restriction: No water, coffee, tea, or other beverages after fasting period begins
    • Medications to Avoid or Modify:
    • Anticoagulants (warfarin, apixaban, dabigatran): Typically discontinued 3-5 days before surgery or as directed by surgeon; bridging therapy may be required for high-risk patients
    • Aspirin and NSAIDs: Generally discontinued 1-2 weeks before surgery to reduce bleeding risk; acetaminophen may be acceptable
    • Herbal supplements: St. John's Wort, ginseng, ginkgo, and other bleeding-risk supplements should be stopped 1-2 weeks prior
    • Diabetic medications: Insulin or oral agents may need adjustment on surgery day; typically held if fasting
    • Blood Pressure Medications: Usually taken with small sip of water on morning of surgery unless otherwise instructed
    • Other Patient Preparation Requirements:
    • Bowel Preparation: Usually not required for neck dissection; however, ensure bowel regularity if prolonged surgery or post-operative immobility expected
    • Skin Preparation: Shower or bathe using surgical scrub (chlorhexidine or povidone-iodine) night before and morning of surgery; hair in surgical field may be clipped (not shaved) on day of surgery
    • Jewelry and Prosthetics: Remove all jewelry, watches, piercings, dentures, hearing aids, and prosthetics before surgery; arrange secure storage
    • Clothing: Wear comfortable, loose-fitting clothes that are easy to remove; plan for potential post-operative swelling and drainage
    • Laboratory Tests: Pre-operative blood work typically includes CBC, comprehensive metabolic panel, coagulation studies (PT/INR, PTT), and blood type and crossmatch
    • Imaging Studies: Pre-operative CT, MRI, or ultrasound may be required for surgical planning; images must be available in operating room
    • Consent and Documentation: Informed consent must be obtained; review all operative risks, benefits, alternatives, and potential complications
    • Arrival Time: Typically arrive 1-2 hours before scheduled surgery for final pre-operative assessment and anesthesia evaluation
    • Escort Requirement: Arrange for responsible adult driver to accompany patient home; patient cannot drive or operate machinery for 24 hours post-operatively due to anesthesia effects

How our test process works!

customers
customers